Sarah Hamren

537 total citations
10 papers, 425 citations indexed

About

Sarah Hamren is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sarah Hamren has authored 10 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sarah Hamren's work include Neuropeptides and Animal Physiology (3 papers), Peptidase Inhibition and Analysis (2 papers) and Receptor Mechanisms and Signaling (2 papers). Sarah Hamren is often cited by papers focused on Neuropeptides and Animal Physiology (3 papers), Peptidase Inhibition and Analysis (2 papers) and Receptor Mechanisms and Signaling (2 papers). Sarah Hamren collaborates with scholars based in United States, Denmark and Canada. Sarah Hamren's co-authors include Michael W. Rowe, Janice A. Kolberg, Xiaomei Xu, Michael P. McKenna, Robert Gerwien, Clark Q. Pan, Mickey S. Urdea, Jian Zhu, Stephanie Yung and Torben Hansen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Diabetes Care.

In The Last Decade

Sarah Hamren

10 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Hamren United States 9 170 126 96 95 65 10 425
V. Bodart Canada 9 194 1.1× 78 0.6× 55 0.6× 114 1.2× 72 1.1× 9 523
Clémence Merlen Canada 11 254 1.5× 53 0.4× 118 1.2× 48 0.5× 43 0.7× 26 414
Donny Strosberg France 7 213 1.3× 57 0.5× 54 0.6× 32 0.3× 21 0.3× 8 371
Hyacinth Paul United States 5 253 1.5× 64 0.5× 66 0.7× 31 0.3× 52 0.8× 7 396
Xian Dong China 10 206 1.2× 27 0.2× 37 0.4× 68 0.7× 26 0.4× 16 412
Augustinas Sakinis Sweden 12 202 1.2× 38 0.3× 33 0.3× 156 1.6× 353 5.4× 16 552
Toshiharu Ishizuka Japan 15 347 2.0× 41 0.3× 26 0.3× 102 1.1× 62 1.0× 33 538
Masahiro Fujii Japan 12 132 0.8× 35 0.3× 72 0.8× 13 0.1× 50 0.8× 52 449
Rosemarie Morwinski Germany 11 222 1.3× 37 0.3× 261 2.7× 33 0.3× 35 0.5× 19 482
Naim Panjwani Canada 7 198 1.2× 30 0.2× 19 0.2× 226 2.4× 150 2.3× 10 443

Countries citing papers authored by Sarah Hamren

Since Specialization
Citations

This map shows the geographic impact of Sarah Hamren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Hamren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Hamren more than expected).

Fields of papers citing papers by Sarah Hamren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Hamren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Hamren. The network helps show where Sarah Hamren may publish in the future.

Co-authorship network of co-authors of Sarah Hamren

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Hamren. A scholar is included among the top collaborators of Sarah Hamren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Hamren. Sarah Hamren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gordon, Leslie B., W. E. Norris, Sarah Hamren, et al.. (2023). Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation. Circulation. 147(23). 1734–1744. 9 indexed citations
2.
Kaier, Thomas E, Eva Denise Martin, O’Neal Copeland, et al.. (2017). Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium. Clinical Chemistry. 63(5). 990–996. 78 indexed citations
3.
Liese, Angela D., Carlos Lorenzo, Steven M. Haffner, et al.. (2015). Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. BMC Gastroenterology. 15(1). 88–88. 15 indexed citations
4.
Wilsgaard, Tom, Ellisiv B. Mathiesen, Anil Patwardhan, et al.. (2015). Clinically Significant Novel Biomarkers for Prediction of First Ever Myocardial Infarction. Circulation Cardiovascular Genetics. 8(2). 363–371. 22 indexed citations
5.
Tarasow, Theodore M., Laura R. Penny, Anil Patwardhan, et al.. (2011). Microfluidic Strategies Applied to Biomarker Discovery and Validation for Multivariate Diagnostics. Bioanalysis. 3(19). 2233–2251. 9 indexed citations
6.
Goldfine, Allison B., Robert Gerwien, Janice A. Kolberg, et al.. (2010). Biomarkers in Fasting Serum to Estimate Glucose Tolerance, Insulin Sensitivity, and Insulin Secretion. Clinical Chemistry. 57(2). 326–337. 11 indexed citations
7.
Kolberg, Janice A., Torben Jørgensen, Robert Gerwien, et al.. (2009). Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort. Diabetes Care. 32(7). 1207–1212. 130 indexed citations
8.
Pan, Clark Q., et al.. (2007). Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line. Peptides. 29(3). 479–486. 4 indexed citations
9.
Yung, Stephanie, Sarah Hamren, Jian Zhu, et al.. (2003). Generation of Highly Selective VPAC2 Receptor Agonists by High Throughput Mutagenesis of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Peptide. Journal of Biological Chemistry. 278(12). 10273–10281. 37 indexed citations
10.
Tsutsumi, Manami, Thomas H. Claus, Yin Liang, et al.. (2002). A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal. Diabetes. 51(5). 1453–1460. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Bodart Breakdown of academic impact, for papers by Clémence Merlen Breakdown of academic impact, for papers by Donny Strosberg Breakdown of academic impact, for papers by Hyacinth Paul Breakdown of academic impact, for papers by Xian Dong Breakdown of academic impact, for papers by Augustinas Sakinis Breakdown of academic impact, for papers by Toshiharu Ishizuka Breakdown of academic impact, for papers by Masahiro Fujii Breakdown of academic impact, for papers by Rosemarie Morwinski Breakdown of academic impact, for papers by Naim Panjwani
Rankless by CCL
2026